SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-17-070956
Filing Date
2017-11-29
Accepted
2017-11-29 16:02:00
Documents
2
Period of Report
2017-11-27

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1638
2 EX-24.1 ex-24d1.htm EX-24.1 9934
  Complete submission text file 0001104659-17-070956.txt   13317
Mailing Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3
Business Address C/O NORTON ROSE FULBRIGHT 1800 - 510 WEST GEORGIA STREET VANCOUVER A1 V6B 0M3 (877) 764-3131
NOVELION THERAPEUTICS INC. (Issuer) CIK: 0000827809 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVELION THERAPEUTICS INC. 1800-510 WEST GEORGIA STREET VANCOUVER A1 V6B OM3
Business Address
Stewart Murray (Reporting) CIK: 0001723450 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-17082 | Film No.: 171228326